Literature DB >> 22160776

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.

Tsuyoshi Homma1, Hiroko Sonoda, Kenichi Manabe, Kiyoshi Arai, Makoto Mizuno, Toshio Sada, Masahiro Ikeda.   

Abstract

Although chronic cardiac dysfunction is known to progressively exacerbate renal injury, a condition known as type 2 cardiorenal syndrome (CRS), the mechanism responsible is largely unknown. The present study was undertaken to clarify the mechanism of renal injury in rats with both unilateral nephrectomy (NX) and surgically induced myocardial infarction (MI), corresponding to a model of type 2 CRS. Compared with a control group, rats with both MI and NX (MI+NX) exhibited progressive proteinuria during the experimental period (34 wk after MI surgery), whereas proteinuria was not observed in rats with MI alone and was moderate in rats with NX alone. The proteinuria in rats with MI+NX was associated with renal lesions such as glomerulosclerosis and infiltration of mononuclear cells and upregulation of the renal proinflammatory and -fibrotic cytokine and angiotensin II type 1a receptor (AT1aR) genes. In contrast, plasma renin activity was lowered in rats with MI+NX. Immunohistochemistry revealed that the increased AT1R protein was present mainly in renal interstitial mononuclear cells. Olmesartan medoxomil, an AT1R blocker, markedly reduced the proteinuria and infiltration of mononuclear cells, whereas spironolactone, a mineralocorticoid receptor blocker, did not. The present findings demonstrate the pathogenetic role of renal interstitial AT1R signaling in a model of type 2 CRS, providing evidence that AT1R blockade can be a useful therapeutic option for this syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160776     DOI: 10.1152/ajprenal.00494.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

Review 1.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

Review 2.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

3.  Myocardial infarction worsens glomerular injury and microalbuminuria in rats with pre-existing renal impairment accompanied by the activation of ER stress and inflammation.

Authors:  Zhifeng Dong; Penglong Wu; Yongguang Li; Yuan Shen; Ping Xin; Shuai Li; Zhihua Wang; Xiaoyan Dai; Wei Zhu; Meng Wei
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

4.  Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction.

Authors:  Zhu-zhi Wen; Mu-yan Cai; Zun Mai; Dong-mei Jin; Yang-xin Chen; Hui Huang; Deng-feng Geng; Jing-feng Wang
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

5.  Aggravated Cardiac Remodeling post Aortocaval Fistula in Unilateral Nephrectomized Rats.

Authors:  Jie Wu; Zhong Cheng; Ye Gu; Wusong Zou; Mingjing Zhang; Pengfei Zhu; Shao Hu
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

6.  Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage.

Authors:  Shan Liu; Bing H Wang; Darren J Kelly; Henry Krum; Andrew R Kompa
Journal:  J Cell Mol Med       Date:  2017-10-10       Impact factor: 5.310

7.  Comparison of renal impairment post-myocardial infarction with reduced and preserved left ventricular function in rats with normal renal function.

Authors:  Zhuzhi Wen; Zun Mai; Xiaolin Zhu; Yangxin Chen; Dengfeng Geng; Jingfeng Wang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 8.  Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function.

Authors:  Michele Ciccarelli; Dana Dawson; Inês Falcao-Pires; Mauro Giacca; Nazha Hamdani; Stéphane Heymans; Astrid Hooghiemstra; Annebet Leeuwis; Dorien Hermkens; Carlo Gabriele Tocchetti; Jolanda van der Velden; Serena Zacchigna; Thomas Thum
Journal:  Cardiovasc Res       Date:  2021-11-01       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.